skip to Main Content
German Trade Group Calls For Greater Emphasis On Domestic Cultivation As Medical Cannabis Imports Soar

A LEADING German cannabis trade association is calling for an increase in homegrown produce as new figures show imports increased by over 80% in the first half of the 2021.

Figures obtained from the Federal Ministry of Health show that almost nine tonnes of medical cannabis flower was imported into Germany compared to almost five tonnes in the corresponding period in 2020.

The Health Ministry’s figures also show that medical cannabis products have now been imported from 17 countries with nine of these being European (see chart below).

Jürgen Neumeyer, Managing Director of the German Cannabis Industry Association (BvCW) says the figures demonstrate the need for Germany to speed-up the development of its homegrown industry.

Germany Should Not Be Left Behind

“The significant increase in imports shows the growing need for medical cannabis in Germany.

“Of the planned domestic cultivation of 2,600 kg per year, as far as we know, only about 50 kg were realised in the first half of the year.

“All in all, our importers are particularly pleased about this development. More and more countries around the world are realising the economic need for cannabis cultivation. That is also to be welcomed. However, we should be careful not to lose touch with the international community in Germany.”

The Federal Institute for Drugs and Medical Devices (BfArM) has issued permits to three companies for domestic cultivation – Aphria, Demecan and Aurora – with the former delivering the first homegrownproduct in July, this year.

Germany’s Cannabis Agency has set an annual upper limit for domestic cultivation of 3.9 tonnes.

Additional data published by the BvCW identifies the 17 exporters – see chart below – with Canada, Holland, Australia and Portugal being the main suppliers.

The release of the Health Ministry figures follows a request by Dr Wieland Schinnenburg, a former Member of the Bundestag.

In a BvCW press release he said: “It is simply incomprehensible why German companies are not in the lucrative export market Instead of becoming more and more dependent on imports, we need more cannabis – Made in Germany. We have to enable German companies for the export market and expand the cultivation of cannabis to 100 tons per year. “

The Health Ministry figures show that 8,966.6kg of cannabis flowers were imported; in 2020, the figure was 4,946.3kg in the same period.

In addition, 980.4kg of dried cannabis flowers were imported in the first half of 2021, which were required for the production of the extracts. In the same period of the previous year the amount was 820.3kg. This corresponds to an increase of approx 19.5%.

The huge surge in imports in the first half of the year comes as medical cannabis patient numbers in Germany have risen to more than 130,000 with a state health insurance programme mostly picking up the costs.

Signs Of A Sophisticated Market Emerging

Benedikt Sons, CEO & Co-Founder of German wholesale medical cannabis distributor Cansativa, said that it is more than likely that some of the imports would have been re-exported to other countries.

He said it was not a surprise that the likes of Canada and the Netherlands are the main suppliers to the market and continued.

“However, it is noticeable that new countries such as Denmark, Portugal and Australia are getting more and more important and are challenging the status quo.

“Additionally, it is surprising that medical cannabis from over 17 countries was imported into Germany: This is a proof of a more and more sophisticated industry with an increasing number of players that are successfully managing the market access challenges resulting from the EU-GMP framework

“What is not reflected in the governmental data yet, is the start of sales of the medical cannabis from domestic cultivation in July: Aphria’s products are available since then, distributed exclusively by Cansativa on behalf of BfArM and it will be exciting to monitor the effects of the medical cannabis domestic cultivation program on the import quantities and origins in the second half of 2021.

“Without any doubt Germany continues to significantly rely on imports as the annual total of 2.6 up to 3.9 tonnes from the domestic medical cannabis programme will not cover the market need for pharmacy dispensaries of more than 15 tonnes annually in 2021 and 2022.”

Total medical cannabis imports for Germany last year totalled 9,249kgs, which represented a 37% increase on 2019.

Peter McCusker

Peter McCusker

Peter McCusker is the Founder and Editor of BusinessCann and an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant. BusinessCann covers the ins and outs of the growing European Regulated Medical Marijuana marketplace. Peter can be reached at [email protected].

BusinessCann is an online news publication, which supports the growth of Europe’s Hemp, CBD and Medicinal Cannabis industries by providing factual and feature articles, comment and profiles on the people and businesses forging its growth and development.
This Post Has One Comment
  1. Growing Cannabis in any country is not difficult at all using Greenhouse technology. Producing Medicine from Cannabis flowers is a challenge.
    Germany can lead in this field with resources and technologies available within.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Move to let legal cannabis businesses open bank accounts stalled again in U.S. Senate

A House provision allowing banks to provide credit cards, checking accounts and other financial services to legal cannabis businesses failed to survive negotiations with the Senate and was left out of legislation setting federal defense policy for the 12 months that began Oct. 1. The House had added the Secure and Fair Enforcement, or SAFE,…

Israel to look into legalizing CBD

Israel is going to look into removing products containing cannabinoid (CBD) – the second-most prevalent active ingredient in marijuana, and one that does not produce psychotropic effects – from the list of dangerous drugs, the Health Ministry said on Tuesday in announcing the establishment of a committee to investigate CBD. “We are examining the removal…

Marijuana may make sleep worse, especially for regular users, study finds

It’s a common assumption among marijuana users: Using weed will help you fall asleep and stay asleep. Scientists, however, aren’t so sure that’s true. “This is an understudied but important area, as many people are increasingly turning to cannabis products as sleep aids,” said sleep specialist Wendy Troxel, a senior behavioral scientist at RAND Corporation, who was not…

What’s In a Number? Why You Should Be Thinking About Your ‘Perfect Order Index’

As the cannabis industry matures, executives have increasingly more access to data to analyze around how efficiently and how accurately they are fulfilling their customers’ demands. It’s paramount to success. Fail to honor your promise to your customer, and they will go elsewhere in the market. Competition is fierce. Fortunately supply chain experts have developed…

More Categories

Back To Top
×Close search
Search